• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Admin please move this board to lost civilizations


<



Similar threads

Replies
0
Views
673
Replies
8
Views
2K
Allergan
anonymous
Replies
7
Views
3K
Allergan
anonymous